Step 1: The scenario is management of systemic lupus erythematosus (SLE) in pregnancy, so drugs must be assessed for fetal safety.
Step 2: Methotrexate is a folate antagonist and is a well-known teratogen and abortifacient. It is absolutely contraindicated in pregnancy because it causes congenital malformations and fetal loss. Therefore it CANNOT be used, making option B the answer.
Step 3: Confirm the safe alternatives. Prednisolone is largely inactivated by placental 11-beta-hydroxysteroid dehydrogenase and is considered acceptable in pregnancy for controlling lupus activity, so option A is allowed.
Step 4: Hydroxychloroquine is regarded as safe and is in fact recommended to be continued throughout pregnancy in lupus, so option D is allowed. Sulfasalazine is also considered compatible with pregnancy (with folate supplementation), so option C is allowed.
Step 5: The drug that cannot be used is methotrexate, option B.